Your privacy, your choice

We use essential cookies to make sure the site can function. We also use optional cookies for advertising, personalisation of content, usage analysis, and social media.

By accepting optional cookies, you consent to the processing of your personal data - including transfers to third parties. Some third parties are outside of the European Economic Area, with varying standards of data protection.

See our privacy policy for more information on the use of your personal data.

for further information and to change your choices.

Skip to main content

Table 5 Operative and postoperative data.

From: Hydroxyethyl starch versus Ringer solution in cardiopulmonary bypass prime solutions (a randomized controlled trial)

 

Group 1

Group 2

P value

ACT (A) value

128 ± 18

132 ± 16

NS

ACT (after protamine)

138 ± 24

143 ± 32

NS

Aortic cross clamp duration (min)

85 ± 11

90 ± 13

NS

Cardiopulmonary bypass duration (min)

100 ± 23

108 ± 25

NS

Prime solution amount (ml)

1500

1500

NS

Fluid added to the pump during CPB (ml)

1360 ± 360

0

0.0001*

Net balance at the pump outlet (ml)

1515 ± 270

590 ± 100

0.0001*

Postoperative blood transfusion (units)

2

2

NS

Postoperative FFP transfusion (units)

2

2

NS

Postoperative drainage (ml)

460 ± 140

430 ± 150

NS

Extubation time (hour)

10 ± 4

9 ± 4,5

NS

Intensive care stay (hour)

47 ± 12

45 ± 10

NS

Creatine clearance at postoperative 72nd hour

68 ± 15

64 ± 15

NS

Discharge time (days)

9 ± 3

8 ± 3

NS

  1. ACT: Active coagulation time; CPB: Cardiopulmonary bypass; FFP: Fresh frozen plasma; NS: Not significant (p > 0.05).